Application of the High-Throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma

The clinical outcomes of pancreatic ductal adenocarcinoma (PDAC) remain dismal, with an estimated five-year survival rate of less than 5%. Early detection and prognostic approaches, including robust biomarkers for PDAC, are critical for improving patient survival. Our goal was to explore the biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Chang, Zhang, Zhou, Wang, Jun, Chiu, Brian C-H, Hou, Lifang, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693877/
https://www.ncbi.nlm.nih.gov/pubmed/31413874
http://dx.doi.org/10.3390/epigenomes3030016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693877/
https://www.ncbi.nlm.nih.gov/pubmed/31413874
http://dx.doi.org/10.3390/epigenomes3030016

Ejemplares similares